Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, ARS Pharmaceuticals Inc’s stock clocked out at $11.19, up 4.48% from its previous closing price of $10.71. In other words, the price has increased by $4.48 from its previous closing price. On the day, 1.27 million shares were traded. SPRY stock price reached its highest trading level at $11.41 during the session, while it also had its lowest trading level at $10.53.
Ratios:
To gain a deeper understanding of SPRY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 17 ’24 when Tanimoto Sarina sold 100,000 shares for $11.67 per share. The transaction valued at 1,167,100 led to the insider holds 1,098,499 shares of the business.
Lowenthal Richard E sold 100,000 shares of SPRY for $1,167,100 on Dec 17 ’24. The PRESIDENT AND CEO now owns 1,098,499 shares after completing the transaction at $11.67 per share. On Dec 12 ’24, another insider, Chakma Justin, who serves as the Chief Business Officer of the company, sold 117,333 shares for $12.27 each. As a result, the insider received 1,439,124 and left with 136,380 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1087505792 and an Enterprise Value of 881269760. For the stock, the TTM Price-to-Sale (P/S) ratio is 442.12 while its Price-to-Book (P/B) ratio in mrq is 5.41. Its current Enterprise Value per Revenue stands at 343.174 whereas that against EBITDA is -14.58.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $5.19. The 50-Day Moving Average of the stock is -17.62%, while the 200-Day Moving Average is calculated to be -2.87%.
Shares Statistics:
It appears that SPRY traded 1.15M shares on average per day over the past three months and 1524880 shares per day over the past ten days. A total of 97.15M shares are outstanding, with a floating share count of 51.12M. Insiders hold about 47.40% of the company’s shares, while institutions hold 42.21% stake in the company. Shares short for SPRY as of 1734048000 were 12656935 with a Short Ratio of 11.03, compared to 1731628800 on 13852113. Therefore, it implies a Short% of Shares Outstanding of 12656935 and a Short% of Float of 24.490000000000002.
